Target Germany! An Integrated Investment Opportunity in Europe’s Leading Cannabis Market
Fully operational, revenue-generating German cannabis group offers an ideal investment opportunity for firms seeking strategic entry, expansion, or synergy within the regulated cannabis, CBD, and industrial hemp markets across Germany and Europe
Listing ID:
29645817710
Licence(s) Held:
German importer/wholesaler (GDP license) and manufacturer (GMP license) of medical cannabis
Seeking €3.9 – €4.2 million investment
Listing Details:
This is a fully operational, revenue-generating cannabis group with integrated operations across both medical cannabis/CBD and industrial hemp verticals.
It is a publicly listed European holding company offering comprehensive exposure to the entire cannabis and industrial hemp value chain.
Backed by a visionary founder-led team with over 100 years of cumulative industry experience, proprietary technology, and strategic partnerships, it offers diversified revenue streams.
The company generated €16 million in 2024, is on track to generate €26 million in revenue for 2025, has a clear path to positive EBITDA by Q1/Q2 2026, with projected revenue of €47 million by 2027.
Healthy gross margins of approximately 32% are projected from 2025–2029.
This integrated powerhouse delivers high-margin, scalable solutions across the entire cannabis and industrial hemp value chains, positioning itself as a leader in the European market.
It provides direct, de-risked access to the rapidly expanding European cannabis market, positioning investors to capitalize on the upcoming EU medical cannabis expansion cycle.
Strategic synergies span several verticals, including Pharmaceutical Distribution (EU-GMP supply chains), Cannabinoid Manufacturing (EU GMP/GDP-compliant production), Product Innovation, Proprietary Technology (patented purification methods), and High-Growth Industrial Hemp Applications (cultivation, extraction, food and feed ingredients, and Novel Food registration pathways).
The company also boasts Digital Health Enablement, with a robust online ecosystem connecting medical cannabis patients, pharmacies, and healthcare professionals, laying the foundation for telehealth and digital prescriptions.
It offers a complete turnkey solution for access to the German and broader European market, with integrated EU operations and global import/export capabilities.
This investment opportunity is ideal for investment firms, public market consolidators, healthcare and pharma companies, cannabis businesses, and food & wellness brands seeking strategic entry, expansion, or synergy within the German and European regulated cannabis, CBD, and industrial hemp markets.
29645817710
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.
45967461758
Leading online patient acquisition & retention platform: 20,000+ active patient ecosystem and full Canadian regulatory compliance
Purpose-built for high-efficiency patient acquisition and retention within the Canadian medical cannabis sector, this low-overhead, tech-enabled platform provides a high-margin gateway for LPs and healthcare practitioners seeking to scale their patient bases quickly. Designed with scalability in mind, the platform is poised to expand into adjacent care segments and international markets
